uniQure will run another trial of its Huntington’s Disease gene therapy following the FDA’s review. Credit: Vink Fan / Shutterstock.com uniQure’s stock has dropped by more than 40% after being asked ...
Early signs of functional improvement were recorded, including a 12-letter gain in BCVA in the treated eye. Credit: Mangza2029 / Shutterstock.com. Opus Genetics has reported early findings from its ...
Keytruda is authorised for adjuvant treatment of certain RCC patients in EU, Canada, Japan and the US. Credit: H_Ko / Shutterstock.com. Merck (MSD) has announced findings from the pivotal Phase III ...
Neuromodulation systems are becoming increasingly popular for the treatment of UUI. Credit: designerNFMR / Shutterstock.com. BlueWind Medical’s Revi implantable tibial neuromodulation (ITNM) system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results